Upregulation of the genes connected to vitamin D and associated IFN-α stimulation (RSAD2, IFI44L) may reflect consequences of an altered vitamin D metabolism in OI patients, underlining a complex effect of the disorder. The gene discussed is IFI44L; the disease is osteogenesis imperfecta.